Glucose, Viaflo Baxter

Glucose, Viaflo Baxter is an intravenous solution containing the simple sugar glucose as its active ingredient. It is supplied in a sterile liquid form for infusion and is marketed within the European Union. The product is used in clinical settings to provide a source of carbohydrate energy, support fluid balance, and assist in the management of hypoglycaemia under medical supervision.

Glucose, Viaflo Baxter is employed in various medical contexts where rapid carbohydrate delivery is required. It is commonly used: - To treat or prevent low blood sugar (hypoglycaemia) in patients unable to take oral glucose. - As an energy source during surgery or intensive care when patients cannot eat. - To replenish fluid and electrolyte balance in patients receiving parenteral nutrition. - In diagnostic procedures such as glucose tolerance testing when administered intravenously. - As a carrier for certain intravenous medications to maintain osmolarity.

Glucose, Viaflo Baxter may cause a range of reactions, most of which are related to the infusion process or the sugar content.

Common: - Mild hyperglycaemia (temporary rise in blood glucose levels). - Local irritation at the infusion site, such as redness or swelling. - Nausea or mild gastrointestinal discomfort. - Headache or dizziness during rapid infusion. - Fluid overload signs, such as mild edema.

Serious: - Severe hyperglycaemia leading to ketoacidosis in susceptible individuals. - Allergic reaction including rash, itching, or anaphylaxis. - Electrolyte imbalance, particularly hyponatraemia. - Venous thrombosis at the catheter site. - Acute renal impairment in patients with pre‑existing kidney disease.

When using Glucose, Viaflo Baxter, healthcare professionals should consider several safety measures. Important precautions include: - Assessing the patient’s blood glucose level before and during infusion. - Adjusting infusion rate in patients with diabetes or impaired glucose tolerance. - Monitoring fluid balance to avoid overload, especially in heart failure or renal insufficiency. - Using aseptic technique to prevent catheter‑related infections. - Checking for contraindications such as known hypersensitivity to glucose solutions. - Evaluating electrolyte status, particularly sodium and potassium levels, before administration.

Glucose, Viaflo Baxter can interact with other medications or conditions, influencing its safety and effectiveness.

Avoid: - Co‑administration with high‑dose insulin without close glucose monitoring. - Simultaneous infusion of hypertonic solutions that may exacerbate hyperglycaemia. - Use in patients with severe hyperosmolar states without correction.

Use with caution: - Concurrent use of diuretics that may affect fluid and electrolyte balance. - Administration alongside catecholamines or glucocorticoids that raise blood glucose. - Patients receiving total parenteral nutrition, requiring careful carbohydrate calculation.